Risk of complications rise with coronary artery disease and diabetes mellitus after endobronchial valve placement in severe heterogeneous emphysema.
Sebastian Fernandez-BussyAnna KornafeldGonzalo LabarcaDavid Abia-TrujilloNeal M PatelMargaret M JohnsonJanani S ReisenauerFelix J HerthPublished in: The clinical respiratory journal (2021)
Our study found that patients with severe, heterogeneous emphysema who undergo ELVR utilizing Zephyr® EBV and suffer complications during post-procedure period are more likely to have CAD or T2DM as baseline comorbidity. These data suggest that baseline CAD and T2DM might be predictive of increased risk of complications following ELVR with EBV.
Keyphrases
- coronary artery disease
- epstein barr virus
- risk factors
- chronic obstructive pulmonary disease
- percutaneous coronary intervention
- early onset
- diffuse large b cell lymphoma
- lung function
- ultrasound guided
- glycemic control
- coronary artery bypass grafting
- cardiovascular events
- idiopathic pulmonary fibrosis
- mitral valve
- aortic valve
- electronic health record
- type diabetes
- minimally invasive
- aortic stenosis
- heart failure
- machine learning
- acute coronary syndrome
- cystic fibrosis
- adipose tissue
- left ventricular
- ejection fraction